Coloplast As Sp/Adr (CLPBY) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the presentation of Investments Abilator's interim report for the second quarter 2025. The first part of the presentation will be in listen-only mode and will then open up for questions. To be able to ask a question, dial star 5 on your telephone keypad or use the chat window. I will now hand over to CEO Johan Hjartalsson and CFO Mikael Jonsson-Albrechtsson. Thank you, Katarina. Very welcome, everybody, to our presentation of the Q2 report 2025. And as Katarina said, I'm here with our new CFO, Mikael Jonsson-Abrexon. So very welcome, Mikael, to your first presentation for the Latour quarterly results. As you can see on the first slide, our overall group structure is unchanged. And despite the challenging business climate and unstable geopolitical situation, we see a continued good performance in our businesses. And we're very happy with that. The general demand is quite good in many of the markets that we operate on, but it varies between regions and industries. We grow organically during the quarter in both order intake and net sales. However, we had some headwind from negative currency effects that affected our gross margin slightly. Despite the short term external instability, we continue to invest in our companies, and this is truly a natural strength. We invest to ensure long term growth and profitability, even in a tougher climate. As you all have seen during the summer, there has been some clarifications regarding the US tariffs during this summer, where imports from Europe will be charged with 15%, but there's still some uncertainty left. For instance, which products are exempted and which materials to mention one area. Latour's exposure in the US corresponds to 11% of our total net sales and the effect from the tariffs are limited for the overall ...